Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment

Liver resections for hepatocellular carcinoma (HCC) in cirrhotic livers are associated with early recurrence and poor survival. Somatostatin analogues (SSAs) have been reported to inhibit cell proliferation by interacting with specific somatostatin receptors (SSTRs) 2 and 5. The present study invest...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, YAO, JIANG, LI, MU, YI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/
https://www.ncbi.nlm.nih.gov/pubmed/24137418
http://dx.doi.org/10.3892/ol.2013.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/
https://www.ncbi.nlm.nih.gov/pubmed/24137418
http://dx.doi.org/10.3892/ol.2013.1435

Ejemplares similares